FDA to Consider Lifting Restrictions on Numerous Compounded Peptides
On April 16, 2026, the U.S. Food & Drug Administration (FDA) announced it will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23 and 24, 2026, to discuss pe...